Table 2

Overview of data collection from consented deceased organ donors

Data typeData capture includes
Monitoring devicesArterial catheter
Central venous catheter
Pulmonary artery catheter
Advanced organ-sustaining therapiesMechanical ventilation
Vasopressors and inotropes
Cardiopulmonary resuscitation
Renal replacement therapy
Fluid resuscitation
Enteral/parenteral nutrition
Prophylactic medicationsGastrointestinal prophylaxis
Pneumonia prophylaxis
Glycaemic control
Donation-specific therapiesGlucocorticosteroids
Thyroid hormone
Vasopressin infusions
DDAVP administration
Therapeutic heparin
Antimicrobial therapy
Potentially adverse ICU exposuresOxygen desaturation (SpO2 <88% for ≥15 min)
Haemodynamic instability (mean arterial pressure <65 mm Hg for ≥15 min or new vasopressors initiated for treatment of hypotension)
Cardiac arrhythmias requiring chemical or electrical cardioversion
Active bleeding requiring blood transfusion
Extremes of body temperature (<36°C or >38.5°C)
Neurological death declarationTime of death
Details related to
apnoea test
Ancillary tests
Cardiocirculatory death declarationSequence of advanced organ-sustaining therapy withdrawal
Changes in dose of palliative medications
Evolution of vital signs after withdrawal of organ-sustaining therapy
Organ suitability assessmentsBlood tests
Chest radiography
Body imaging
Coronary angiography
Microbiological cultures
Time and rationale for organ decline
Transplant recipientsAge
Panel reactive antigen
Transplant programme
Transplant date
  • ICU, intensive care unit.